Wednesday, July 8, 2026

pharma · Chronic Spontaneous Urticaria (CSU) · Asthma · SPRY

Ars Pharmaceuticals Irl

Ars Pharmaceuticals Irl is a pharma organization headquartered in San Diego, USA. It trades on NYSE under ticker SPRY. Primary therapeutic focus areas include Chronic Spontaneous Urticaria (CSU), Asthma, Urticaria, Upper

San Diego, USA HQ
187 Employees
Public company Type
SPRY · NYSE Ticker
Company details
Status
Public
HQ
San Diego, USA
Employees
187
Programs
8
Drugs
7
Patents
0
Clinical program

Neffy

Approved · small molecule · Allergic Reactions

Neffy for Allergic Reactions is a Approved program (small_molecule) at Ars Pharmaceuticals Irl Limited with 1 ClinicalTrials.gov record(s).

Internal code EPI R01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Ars Pharmaceuticals Irl Limited
Phase
Approved
Modality
small_molecule
Indication
Allergic Reactions
Status
active
Trials
1